See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Liberation Day
Tariffs
Donald Trump
Trade War
Natural Disasters
Baseball
Senate
Republican Party
Social Media
Artificial Intelligence
Democratic Party
Tennis
Published • loading... • Updated

Beyonttra™ (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved in Japan to Treat ATTR-CM

Summary by Inside Ottawa Valley
In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated

4 Articles

All
Left
2
Center
Right
Simcoe.comSimcoe.com
Reposted by
Inside Ottawa ValleyInside Ottawa Valley
Lean Left

Beyonttra™ (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved in Japan to Treat ATTR-CM

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-tolerated

Read Full Article
hcplive.comhcplive.com

RX Review: Impact of New, Upcoming Therapies for ATTR-CM

In this video, part 3 of a 4-part series, panelists discuss the impact of recent approvals and pipeline developments on the outlook for ATTR-CM management.

Read Full Article
Pharmaceutical Business reviewPharmaceutical Business review

BridgeBio’s Beyonttra gains approval in Japan for ATTR-CM treatment

Acoramidis is a selective small molecule that is orally administered. ATTR-CM is a progressive, restrictive cardiomyopathy that leads to heart failure. BridgeBio Cardiorenal chief medical officer Dr Jonathan The post BridgeBio’s Beyonttra gains approval in Japan for ATTR-CM treatment appeared first on Pharmaceutical Business review.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Inside Ottawa Valley broke the news in Ottawa, Canada on Thursday, March 27, 2025.
Sources are mostly out of (0)

Similar News Topics

Japan

Japan

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal